ReP USP - Resultado da busca

Artigo de periodico
Eribulin exerts multitarget antineoplastic activity in glioma cells (2025)
Alcântara, Guilherme Augusto Sousa ; Nascimento, Mariane Cristina do ; Miranda, Lívia Bassani Lins De ; Almeida, Bruna Oliveira de ; Lima, Keli ; Rego, Eduardo Magalhães ; Costa-Lotufo, Letícia Veras ; Machado Neto, João Agostinho
Source: Pharmacological Reports. Unidades: FM, ICB
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, GLIOMA, PROLIFERAÇÃO CELULAR, NEOPLASIAS CEREBRAIS, ANTINEOPLÁSICOS, APOPTOSE, CICLO CELULAR, SOBREVIVÊNCIA CELULAR, CITOMETRIA DE FLUXO, WESTERN BLOTTING
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALCÂNTARA, Guilherme Augusto Sousa et al. Eribulin exerts multitarget antineoplastic activity in glioma cells. Pharmacological Reports, v. 77, n. 3, p. 817-828, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/87051. Acesso em: 01 maio 2026.
APA
Alcântara, G. A. S., Nascimento, M. C. do, Miranda, L. B. L. D., Almeida, B. O. de, Lima, K., Rego, E. M., et al. (2025). Eribulin exerts multitarget antineoplastic activity in glioma cells. Pharmacological Reports, 77( 3), 817-828. doi:10.1007/s43440-025-00711-y
NLM
Alcântara GAS, Nascimento MC do, Miranda LBLD, Almeida BO de, Lima K, Rego EM, Costa-Lotufo LV, Machado Neto JA. Eribulin exerts multitarget antineoplastic activity in glioma cells [Internet]. Pharmacological Reports. 2025 ; 77( 3): 817-828.[citado 2026 maio 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/87051
Vancouver
Alcântara GAS, Nascimento MC do, Miranda LBLD, Almeida BO de, Lima K, Rego EM, Costa-Lotufo LV, Machado Neto JA. Eribulin exerts multitarget antineoplastic activity in glioma cells [Internet]. Pharmacological Reports. 2025 ; 77( 3): 817-828.[citado 2026 maio 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/87051
Artigo de periodico
Cannabidiol attenuates generalized tonic–clonic and suppresses limbic seizures in the genetically epilepsy-prone rats (GEPR-3) strain (2023)
Lopes, Willian Lazarini; Campos-Rodriguez, Carolina; Garcia-Cairasco, Norberto; N’Gouemo, Prosper; Forcelli, Patrick A.
Source: Pharmacological Reports. Unidade: FMRP
Subjects: ESTIMULAÇÃO AUDITIVA, TRONCO CEREBRAL, CANABINOIDES, CONVULSÕES, FARMACOTERAPIA, RATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Willian Lazarini et al. Cannabidiol attenuates generalized tonic–clonic and suppresses limbic seizures in the genetically epilepsy-prone rats (GEPR-3) strain. Pharmacological Reports, v. 75, n. 1, p. 166-176, 2023Tradução . . Disponível em: https://doi.org/10.1007/s43440-022-00416-6. Acesso em: 01 maio 2026.
APA
Lopes, W. L., Campos-Rodriguez, C., Garcia-Cairasco, N., N’Gouemo, P., & Forcelli, P. A. (2023). Cannabidiol attenuates generalized tonic–clonic and suppresses limbic seizures in the genetically epilepsy-prone rats (GEPR-3) strain. Pharmacological Reports, 75( 1), 166-176. doi:10.1007/s43440-022-00416-6
NLM
Lopes WL, Campos-Rodriguez C, Garcia-Cairasco N, N’Gouemo P, Forcelli PA. Cannabidiol attenuates generalized tonic–clonic and suppresses limbic seizures in the genetically epilepsy-prone rats (GEPR-3) strain [Internet]. Pharmacological Reports. 2023 ; 75( 1): 166-176.[citado 2026 maio 01 ] Available from: https://doi.org/10.1007/s43440-022-00416-6
Vancouver
Lopes WL, Campos-Rodriguez C, Garcia-Cairasco N, N’Gouemo P, Forcelli PA. Cannabidiol attenuates generalized tonic–clonic and suppresses limbic seizures in the genetically epilepsy-prone rats (GEPR-3) strain [Internet]. Pharmacological Reports. 2023 ; 75( 1): 166-176.[citado 2026 maio 01 ] Available from: https://doi.org/10.1007/s43440-022-00416-6
Artigo de periodico
Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts (2022)
Hernandez, Carolina Dagli ; Zhou, Yitian; Lauschke, Volker Martin; Genvigir, Fabiana Dalla Vecchia ; Hirata, Thiago Dominguez Crespo ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacological Reports. Unidade: FCF
Subjects: ESTATINAS, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts. Pharmacological Reports, v. 74, p. 47–66, 2022Tradução . . Disponível em: https://doi.org/10.1007/s43440-021-00319-y. Acesso em: 01 maio 2026.
APA
Hernandez, C. D., Zhou, Y., Lauschke, V. M., Genvigir, F. D. V., Hirata, T. D. C., Hirata, M. H., & Hirata, R. D. C. (2022). Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts. Pharmacological Reports, 74, 47–66. doi:10.1007/s43440-021-00319-y
NLM
Hernandez CD, Zhou Y, Lauschke VM, Genvigir FDV, Hirata TDC, Hirata MH, Hirata RDC. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts [Internet]. Pharmacological Reports. 2022 ; 74 47–66.[citado 2026 maio 01 ] Available from: https://doi.org/10.1007/s43440-021-00319-y
Vancouver
Hernandez CD, Zhou Y, Lauschke VM, Genvigir FDV, Hirata TDC, Hirata MH, Hirata RDC. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts [Internet]. Pharmacological Reports. 2022 ; 74 47–66.[citado 2026 maio 01 ] Available from: https://doi.org/10.1007/s43440-021-00319-y
Artigo de periodico
Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells (2021)
Cerda, Alvaro ; Bortolin, Raul Hernandes ; Manriquez, Victor; Salazar, Luis A ; Zambrano, Tomás ; Fajardo, Cristina Moreno ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacological Reports. Unidade: FCF
Subjects: MICRORNAS, LIPÍDEOS, MICRORNAS, EXPRESSÃO GÊNICA, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells. Pharmacological Reports, v. 73, p. 1-13 art. 868–880, 2021Tradução . . Disponível em: https://doi.org/10.1007/s43440-021-00241-3. Acesso em: 01 maio 2026.
APA
Cerda, A., Bortolin, R. H., Manriquez, V., Salazar, L. A., Zambrano, T., Fajardo, C. M., et al. (2021). Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells. Pharmacological Reports, 73, 1-13 art. 868–880. doi:10.1007/s43440-021-00241-3
NLM
Cerda A, Bortolin RH, Manriquez V, Salazar LA, Zambrano T, Fajardo CM, Hirata MH, Hirata RDC. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells [Internet]. Pharmacological Reports. 2021 ; 73 1-13 art. 868–880.[citado 2026 maio 01 ] Available from: https://doi.org/10.1007/s43440-021-00241-3
Vancouver
Cerda A, Bortolin RH, Manriquez V, Salazar LA, Zambrano T, Fajardo CM, Hirata MH, Hirata RDC. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells [Internet]. Pharmacological Reports. 2021 ; 73 1-13 art. 868–880.[citado 2026 maio 01 ] Available from: https://doi.org/10.1007/s43440-021-00241-3
Artigo de periodico
Preclinical toxicological study of prolonged exposure to ketamine as an antidepressant (2020)
Zaccarelli‐Magalhães, Julia ; Fukushima, André Rinaldi ; Moreira, Natalia; Manes, Marianna ; Abreu, Gabriel Ramos de ; Ricci, Esther Lopes ; Waziry, Paula A. Faria ; Spinosa, Helenice de Souza
Source: Pharmacological Reports. Unidade: FMVZ
Subjects: ANÁLISE TOXICOLÓGICA, ANTIDEPRESSIVOS, BIOQUÍMICA, NEUROQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZACCARELLI‐MAGALHÃES, Julia et al. Preclinical toxicological study of prolonged exposure to ketamine as an antidepressant. Pharmacological Reports, v. 72, p. 24-35, 2020Tradução . . Disponível em: https://doi.org/10.1007/s43440-019-00014-z. Acesso em: 01 maio 2026.
APA
Zaccarelli‐Magalhães, J., Fukushima, A. R., Moreira, N., Manes, M., Abreu, G. R. de, Ricci, E. L., et al. (2020). Preclinical toxicological study of prolonged exposure to ketamine as an antidepressant. Pharmacological Reports, 72, 24-35. doi:10.1007/s43440-019-00014-z
NLM
Zaccarelli‐Magalhães J, Fukushima AR, Moreira N, Manes M, Abreu GR de, Ricci EL, Waziry PAF, Spinosa H de S. Preclinical toxicological study of prolonged exposure to ketamine as an antidepressant [Internet]. Pharmacological Reports. 2020 ; 72 24-35.[citado 2026 maio 01 ] Available from: https://doi.org/10.1007/s43440-019-00014-z
Vancouver
Zaccarelli‐Magalhães J, Fukushima AR, Moreira N, Manes M, Abreu GR de, Ricci EL, Waziry PAF, Spinosa H de S. Preclinical toxicological study of prolonged exposure to ketamine as an antidepressant [Internet]. Pharmacological Reports. 2020 ; 72 24-35.[citado 2026 maio 01 ] Available from: https://doi.org/10.1007/s43440-019-00014-z
Artigo de periodico
Chronic activation of GPR40 does not negatively impact upon BRIN-BD11 pancreatic β-cell physiology and function (2020)
Vilas-Boas, Eloisa Aparecida ; Karabacz, Noémie; Librais, Gabriela Nunes Marsiglio ; Valle, Maíra Mello Rezende ; Nalbach, Lisa; Ampofo, Emmanuel; Morgan, Bruce ; Carpinelli, Angelo Rafael ; Roma, Leticia Prates
Source: Pharmacological Reports. Unidade: ICB
Subjects: FISIOLOGIA, ÁCIDOS GRAXOS, INSULINA, ESTRESSE OXIDATIVO, PÂNCREAS, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VILAS-BOAS, Eloisa Aparecida et al. Chronic activation of GPR40 does not negatively impact upon BRIN-BD11 pancreatic β-cell physiology and function. Pharmacological Reports, v. 72, n. 6, p. 1725-1737, 2020Tradução . . Disponível em: https://doi.org/10.1007/s43440-020-00101-6. Acesso em: 01 maio 2026.
APA
Vilas-Boas, E. A., Karabacz, N., Librais, G. N. M., Valle, M. M. R., Nalbach, L., Ampofo, E., et al. (2020). Chronic activation of GPR40 does not negatively impact upon BRIN-BD11 pancreatic β-cell physiology and function. Pharmacological Reports, 72( 6), 1725-1737. doi:10.1007/s43440-020-00101-6
NLM
Vilas-Boas EA, Karabacz N, Librais GNM, Valle MMR, Nalbach L, Ampofo E, Morgan B, Carpinelli AR, Roma LP. Chronic activation of GPR40 does not negatively impact upon BRIN-BD11 pancreatic β-cell physiology and function [Internet]. Pharmacological Reports. 2020 ; 72( 6): 1725-1737.[citado 2026 maio 01 ] Available from: https://doi.org/10.1007/s43440-020-00101-6
Vancouver
Vilas-Boas EA, Karabacz N, Librais GNM, Valle MMR, Nalbach L, Ampofo E, Morgan B, Carpinelli AR, Roma LP. Chronic activation of GPR40 does not negatively impact upon BRIN-BD11 pancreatic β-cell physiology and function [Internet]. Pharmacological Reports. 2020 ; 72( 6): 1725-1737.[citado 2026 maio 01 ] Available from: https://doi.org/10.1007/s43440-020-00101-6
Artigo de periodico
Regulation of murine arthritis by systemic, spinal, and intra-articular adrenoceptors (2019)
Kanashiro, Alexandre; Leoncio, Thais Oliveira de Lucena; Schneider, Ayda Henriques; Alves, Hélio Rocha; Bassi, Gabriel Shimizu; Dutra, Sabrina Graziani Veloso; Cunha, Fernando de Queiroz ; Ulloa, Luis; Malvar, David do Carmo
Source: Pharmacological Reports. Unidade: FMRP
Subjects: ADRENORECEPTORES, ARTRITE, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KANASHIRO, Alexandre et al. Regulation of murine arthritis by systemic, spinal, and intra-articular adrenoceptors. Pharmacological Reports, v. 71, n. 6, p. 1095-1103, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.pharep.2019.06.010. Acesso em: 01 maio 2026.
APA
Kanashiro, A., Leoncio, T. O. de L., Schneider, A. H., Alves, H. R., Bassi, G. S., Dutra, S. G. V., et al. (2019). Regulation of murine arthritis by systemic, spinal, and intra-articular adrenoceptors. Pharmacological Reports, 71( 6), 1095-1103. doi:10.1016/j.pharep.2019.06.010
NLM
Kanashiro A, Leoncio TO de L, Schneider AH, Alves HR, Bassi GS, Dutra SGV, Cunha F de Q, Ulloa L, Malvar D do C. Regulation of murine arthritis by systemic, spinal, and intra-articular adrenoceptors [Internet]. Pharmacological Reports. 2019 ; 71( 6): 1095-1103.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/j.pharep.2019.06.010
Vancouver
Kanashiro A, Leoncio TO de L, Schneider AH, Alves HR, Bassi GS, Dutra SGV, Cunha F de Q, Ulloa L, Malvar D do C. Regulation of murine arthritis by systemic, spinal, and intra-articular adrenoceptors [Internet]. Pharmacological Reports. 2019 ; 71( 6): 1095-1103.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/j.pharep.2019.06.010
Artigo de periodico
In vitro evidence that endothelium-dependent vasodilatation induced by clozapine is mediated by an ATP-sensitive potassium channel (2019)
Mateus, Luiza Silva; Albuquerque, Agnes Afrodite Sumarelli; Celotto, Andréa Carla ; Évora, Paulo Roberto Barbosa
Source: Pharmacological Reports. Unidade: FMRP
Subjects: VASODILATAÇÃO, ANTIPSICÓTICOS, ENDOTÉLIO, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATEUS, Luiza Silva et al. In vitro evidence that endothelium-dependent vasodilatation induced by clozapine is mediated by an ATP-sensitive potassium channel. Pharmacological Reports, v. 71, p. 522-527, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.pharep.2019.02.010. Acesso em: 01 maio 2026.
APA
Mateus, L. S., Albuquerque, A. A. S., Celotto, A. C., & Évora, P. R. B. (2019). In vitro evidence that endothelium-dependent vasodilatation induced by clozapine is mediated by an ATP-sensitive potassium channel. Pharmacological Reports, 71, 522-527. doi:10.1016/j.pharep.2019.02.010
NLM
Mateus LS, Albuquerque AAS, Celotto AC, Évora PRB. In vitro evidence that endothelium-dependent vasodilatation induced by clozapine is mediated by an ATP-sensitive potassium channel [Internet]. Pharmacological Reports. 2019 ; 71 522-527.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/j.pharep.2019.02.010
Vancouver
Mateus LS, Albuquerque AAS, Celotto AC, Évora PRB. In vitro evidence that endothelium-dependent vasodilatation induced by clozapine is mediated by an ATP-sensitive potassium channel [Internet]. Pharmacological Reports. 2019 ; 71 522-527.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/j.pharep.2019.02.010
Artigo de periodico
Mechanisms underlying the hyperalgesic responses triggered by joint activation of TLR4 (2016)
Guerrero, Ana T. G.; Pinto, Larissa G.; Cunha, Fernando de Queiroz; Ferreira, Sérgio Henrique; Alves Filho, José Carlos Farias; Verri, Waldiceu A.; Cunha, Thiago Mattar
Source: Pharmacological Reports. Unidade: FMRP
Subjects: ARTRITE, CITOCINAS, ARTICULAÇÕES, DOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUERRERO, Ana T. G. et al. Mechanisms underlying the hyperalgesic responses triggered by joint activation of TLR4. Pharmacological Reports, v. 68, n. 6, p. 1293-1300, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.pharep.2016.08.006. Acesso em: 01 maio 2026.
APA
Guerrero, A. T. G., Pinto, L. G., Cunha, F. de Q., Ferreira, S. H., Alves Filho, J. C. F., Verri, W. A., & Cunha, T. M. (2016). Mechanisms underlying the hyperalgesic responses triggered by joint activation of TLR4. Pharmacological Reports, 68( 6), 1293-1300. doi:10.1016/j.pharep.2016.08.006
NLM
Guerrero ATG, Pinto LG, Cunha F de Q, Ferreira SH, Alves Filho JCF, Verri WA, Cunha TM. Mechanisms underlying the hyperalgesic responses triggered by joint activation of TLR4 [Internet]. Pharmacological Reports. 2016 ; 68( 6): 1293-1300.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/j.pharep.2016.08.006
Vancouver
Guerrero ATG, Pinto LG, Cunha F de Q, Ferreira SH, Alves Filho JCF, Verri WA, Cunha TM. Mechanisms underlying the hyperalgesic responses triggered by joint activation of TLR4 [Internet]. Pharmacological Reports. 2016 ; 68( 6): 1293-1300.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/j.pharep.2016.08.006
Artigo de periodico
Nitroxyl inhibits overt pain-like behavior in mice: role of cGMP/PKG/ATP-sensitive potassium channel signaling pathway (2014)
Staurengo-Ferrari, Larissa; Zarpelon, Ana C; Longhi-Balbinot, Daniela T; Marchesi, Mario; Cunha, Thiago Mattar; Alves Filho, José Carlos Farias; Cunha, Fernando de Queiroz; Ferreira, Sérgio Henrique; Casagrande, Rubia; Miranda, Katrina M; Verri Junior, Waldiceu A
Source: Pharmacological Reports. Unidade: FMRP
Subjects: ANALGÉSICOS (FARMACOLOGIA), DOR (MEDIÇÃO), TRANSDUÇÃO DE SINAL CELULAR (EFEITOS DE DROGAS), COMPORTAMENTO ANIMAL (EFEITOS DE DROGAS), PROTEÍNAS QUINASES (METABOLISMO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STAURENGO-FERRARI, Larissa et al. Nitroxyl inhibits overt pain-like behavior in mice: role of cGMP/PKG/ATP-sensitive potassium channel signaling pathway. Pharmacological Reports, v. 66, n. 4, p. 691-698, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.pharep.2014.04.003. Acesso em: 01 maio 2026.
APA
Staurengo-Ferrari, L., Zarpelon, A. C., Longhi-Balbinot, D. T., Marchesi, M., Cunha, T. M., Alves Filho, J. C. F., et al. (2014). Nitroxyl inhibits overt pain-like behavior in mice: role of cGMP/PKG/ATP-sensitive potassium channel signaling pathway. Pharmacological Reports, 66( 4), 691-698. doi:10.1016/j.pharep.2014.04.003
NLM
Staurengo-Ferrari L, Zarpelon AC, Longhi-Balbinot DT, Marchesi M, Cunha TM, Alves Filho JCF, Cunha F de Q, Ferreira SH, Casagrande R, Miranda KM, Verri Junior WA. Nitroxyl inhibits overt pain-like behavior in mice: role of cGMP/PKG/ATP-sensitive potassium channel signaling pathway [Internet]. Pharmacological Reports. 2014 ; 66( 4): 691-698.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/j.pharep.2014.04.003
Vancouver
Staurengo-Ferrari L, Zarpelon AC, Longhi-Balbinot DT, Marchesi M, Cunha TM, Alves Filho JCF, Cunha F de Q, Ferreira SH, Casagrande R, Miranda KM, Verri Junior WA. Nitroxyl inhibits overt pain-like behavior in mice: role of cGMP/PKG/ATP-sensitive potassium channel signaling pathway [Internet]. Pharmacological Reports. 2014 ; 66( 4): 691-698.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/j.pharep.2014.04.003
Artigo de periodico
Comparative effects of short-term and long-term insulin-induced hypoglycemia on glucose production in the perfused livers of weaned rats (2011)
Rodrigues, Romir; Feitosa, Kassia P. S.; Felisberto Junior, Antonio M.; Barrena, Helenton C.; Curi, Rui; Bazzotte, Roberto B.
Source: Pharmacological Reports. Unidade: ICB
Assunto: FISIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Romir et al. Comparative effects of short-term and long-term insulin-induced hypoglycemia on glucose production in the perfused livers of weaned rats. Pharmacological Reports, v. 63, n. 5, p. 1252-1257, 2011Tradução . . Disponível em: https://doi.org/10.1016/s1734-1140(11)70647-8. Acesso em: 01 maio 2026.
APA
Rodrigues, R., Feitosa, K. P. S., Felisberto Junior, A. M., Barrena, H. C., Curi, R., & Bazzotte, R. B. (2011). Comparative effects of short-term and long-term insulin-induced hypoglycemia on glucose production in the perfused livers of weaned rats. Pharmacological Reports, 63( 5), 1252-1257. doi:10.1016/s1734-1140(11)70647-8
NLM
Rodrigues R, Feitosa KPS, Felisberto Junior AM, Barrena HC, Curi R, Bazzotte RB. Comparative effects of short-term and long-term insulin-induced hypoglycemia on glucose production in the perfused livers of weaned rats [Internet]. Pharmacological Reports. 2011 ; 63( 5): 1252-1257.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/s1734-1140(11)70647-8
Vancouver
Rodrigues R, Feitosa KPS, Felisberto Junior AM, Barrena HC, Curi R, Bazzotte RB. Comparative effects of short-term and long-term insulin-induced hypoglycemia on glucose production in the perfused livers of weaned rats [Internet]. Pharmacological Reports. 2011 ; 63( 5): 1252-1257.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/s1734-1140(11)70647-8
Artigo de periodico
Anti-inflammatory effects of LASSBio-998, a new drug candidate designed to be a p38 MAPK inhibitor, in an experimental model of acute lung inflammation (2011)
Lima, Aline C. Brando; Machado, Alexandre Leal; Simon, Patrícia; Cavalcante, Moisés M.; Rezende, Daniele C.; Silva, Gilberto M. Sperandio; Nascimento, Paulo Gustavo Barboni Dantas; Quintas, Luis Eduardo Menezes; Cunha, Fernando de Queiroz; Barreiro, Eliezer Jesus; Lima, Lídia Moreira; Koatz, Vera L. G.
Source: Pharmacological Reports. Unidade: FMRP
Assunto: ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Aline C. Brando et al. Anti-inflammatory effects of LASSBio-998, a new drug candidate designed to be a p38 MAPK inhibitor, in an experimental model of acute lung inflammation. Pharmacological Reports, v. 63, n. 4, p. 1029-1039, 2011Tradução . . Disponível em: https://doi.org/10.1016/s1734-1140(11)70619-3. Acesso em: 01 maio 2026.
APA
Lima, A. C. B., Machado, A. L., Simon, P., Cavalcante, M. M., Rezende, D. C., Silva, G. M. S., et al. (2011). Anti-inflammatory effects of LASSBio-998, a new drug candidate designed to be a p38 MAPK inhibitor, in an experimental model of acute lung inflammation. Pharmacological Reports, 63( 4), 1029-1039. doi:10.1016/s1734-1140(11)70619-3
NLM
Lima ACB, Machado AL, Simon P, Cavalcante MM, Rezende DC, Silva GMS, Nascimento PGBD, Quintas LEM, Cunha F de Q, Barreiro EJ, Lima LM, Koatz VLG. Anti-inflammatory effects of LASSBio-998, a new drug candidate designed to be a p38 MAPK inhibitor, in an experimental model of acute lung inflammation [Internet]. Pharmacological Reports. 2011 ; 63( 4): 1029-1039.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/s1734-1140(11)70619-3
Vancouver
Lima ACB, Machado AL, Simon P, Cavalcante MM, Rezende DC, Silva GMS, Nascimento PGBD, Quintas LEM, Cunha F de Q, Barreiro EJ, Lima LM, Koatz VLG. Anti-inflammatory effects of LASSBio-998, a new drug candidate designed to be a p38 MAPK inhibitor, in an experimental model of acute lung inflammation [Internet]. Pharmacological Reports. 2011 ; 63( 4): 1029-1039.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/s1734-1140(11)70619-3
Artigo de periodico
Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys (2006)
Behling, Estela Beatriz; Sendão, Milena C.; Francescato, Heloísa D. C.; Antunes, Lusânia Maria Greggi; Costa, Roberto Silva; Bianchi, Maria de Lourdes Pires
Source: Pharmacological Reports. Unidades: FCFRP, FMRP
Subjects: NEFROPATIAS, ESTRESSE OXIDATIVO, RATOS, ANTIOXIDANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BEHLING, Estela Beatriz et al. Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys. Pharmacological Reports, v. 58, n. 4, p. 526-532, 2006Tradução . . Acesso em: 01 maio 2026.
APA
Behling, E. B., Sendão, M. C., Francescato, H. D. C., Antunes, L. M. G., Costa, R. S., & Bianchi, M. de L. P. (2006). Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys. Pharmacological Reports, 58( 4), 526-532.
NLM
Behling EB, Sendão MC, Francescato HDC, Antunes LMG, Costa RS, Bianchi M de LP. Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys. Pharmacological Reports. 2006 ; 58( 4): 526-532.[citado 2026 maio 01 ]
Vancouver
Behling EB, Sendão MC, Francescato HDC, Antunes LMG, Costa RS, Bianchi M de LP. Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys. Pharmacological Reports. 2006 ; 58( 4): 526-532.[citado 2026 maio 01 ]

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration